Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Strong-Buy at StockNews.com
StockNews.com upgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a buy rating to a strong-buy rating in a report issued on Friday morning. A number of other equities research analysts also recently issued reports on VRTX. Robert W. Baird downgraded shares of Vertex Pharmaceuticals from a neutral rating to an underperform rating and […]